Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Vinorelbine With Paclitaxel in the Treatment of Hormone-Refractory Prostate Cancer

NCT00003622 is registered in ClinicalTrials.gov with James Ahlgren as lead sponsor.

NCT NCT00003622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Vinorelbine With Paclitaxel in the Treatment of Hormone-Refractory Prostate Cancer
Lead sponsor
James Ahlgren
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 1999
Completion date
February 22, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer